Related Experiment Video
Updated: Aug 6, 2026

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
Published on: June 14, 2017
Carbonic anhydrase XIII
1NEUROFARBA Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Firenze, Italy.
Carbonic anhydrase XIII (CA XIII) is a cytosolic enzyme with moderate activity, widely expressed in human tissues. Its roles in health and disease, including cancer, are emerging, with potential as a drug target.
Area of Science:
- Biochemistry
- Enzymology
- Molecular Biology
Background:
- Carbonic anhydrase XIII (CA XIII) is a cytosolic α-carbonic anhydrase identified in 2004.
- It possesses conserved structural and catalytic features, moderate catalytic activity, and distinct proton transfer dynamics.
- CA XIII is broadly expressed in human tissues, particularly epithelial and reproductive systems.
Purpose of the Study:
- To review the characterized features of Carbonic anhydrase XIII.
- To explore its physiological roles and involvement in pathological processes.
- To discuss its potential as a target for drug design.
Main Methods:
- Literature review of published studies on CA XIII.
- Analysis of gene organization, protein structure, catalytic mechanisms, and inhibition profiles.
- Synthesis of evidence linking CA XIII to various physiological and pathological conditions.
Main Results:
- CA XIII exhibits moderate catalytic efficiency due to unique proton transfer dynamics.
- It is widely expressed, suggesting roles in pH regulation, bicarbonate metabolism, and homeostasis.
- Evidence links CA XIII to colorectal cancer (downregulation), breast cancer (tumor suppression), and acute myeloid leukemia (context-dependent roles).
- Associations with inflammation, aging, and cognition suggest broader biological relevance.
Conclusions:
- CA XIII's physiological function requires further elucidation.
- Its involvement in diverse pathologies highlights its clinical significance.
- CA XIII is a potential target for isozyme-selective drug development, though in vivo models are needed.
More Related Videos
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Carbon Dioxide Transport in the Blood
Forms of CO2 Transport
1. Dissolved in plasma: A small percentage (7-10%) of CO2 is transported and dissolved directly in the plasma.
2. Carbaminohemoglobin: Just over 20% of CO2 is chemically bound to...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Cell Specific Gene Expression
X-Inactivation